Gemcitabine in combination with epibrassinolide enhanced the apoptotic response in an ER stress-dependent manner and reduced the epithelial-mesenchymal transition in pancreatic cancer cells

Gemcitabine is a broad-spectrum antimetabolite and a deoxycytidine analog recognized as a standard therapy alone or in combination with other antineoplastic agents in the therapy of pancreas cancer. Drug resistance following gemcitabine treatment is a common phenomenon; therefore, combinational ther...

Descripción completa

Detalles Bibliográficos
Autores principales: OBAKAN YERLİKAYA, Pınar, MEHDIZADEHTAPEH, Leila, RENCÜZOĞULLARI, Özge, KURYAYEVA, Fadina, ÇEVİKLİ, Sena Sedef, ÖZAĞAR, Şevval, ODABAŞ, Sibel Pınar, TUNÇKOL, Sude, YETİM, Hakan, ÇOKER GÜRKAN, Ajda, ARISAN, Elif Damla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Scientific and Technological Research Council of Turkey (TUBITAK) 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387961/
https://www.ncbi.nlm.nih.gov/pubmed/37529796
http://dx.doi.org/10.55730/1300-0152.2630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387961/
https://www.ncbi.nlm.nih.gov/pubmed/37529796
http://dx.doi.org/10.55730/1300-0152.2630

Ejemplares similares